Meitav Dash Investments LTD Neuro Sense Therapeutics Ltd. Call Options Transaction History
Meitav Dash Investments LTD
- $6.32 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
12Shares Held
181KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY50.5KShares$63,6310.0% of portfolio
-
Squarepoint Ops LLC New York, NY49.9KShares$62,9050.0% of portfolio
-
Commonwealth Equity Services, LLC21.1KShares$26,5600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.9KShares$19,9960.0% of portfolio
-
Marshall Wace, LLP London, X011.8KShares$14,9030.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $14.7M